Evidence map›Paper›PMID 37123257›Full record

ArticleFrontiers in physiology2023

Toward accurate cerebral blood flow estimation in mice after accounting for anesthesia.

Zhiliang Wei, Yuguo Li, Adnan Bibic, Wenzhen Duan, Jiadi Xu, Hanzhang Lu

Abstract read
In one paragraph

Article in Frontiers in physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Assessment of early-phase [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhiliang WeiRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Yuguo LiRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Adnan BibicF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Research Institute, Baltimore, MD, United States.
Wenzhen DuanDivision of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Jiadi XuRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Hanzhang LuRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Funding

TRD 4: Platforms for multi-modal and multi-scale imaging dataP41EB031771 · NIBIB · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI Hanzhang Lu, Peter CM Van Zijl · 2021 to 2026
$9.9M
Advanced MRI biomarkers in HD mouse models translatable to humans: nature history and response to therapeuticsR01NS124084 · NINDS · JOHNS HOPKINS UNIVERSITY · PI DUAN, WENZHEN · 2022 to 2025
$2.6M
Non-contrast MR imaging of blood-brain-barrier permeability in Alzheimer's diseaseR01AG064792 · NIA · JOHNS HOPKINS UNIVERSITY · PI LU, HANZHANG · 2020 to 2023
$2.6M
Blood-brain barrier dysfunction in Alzheimer's disease: from humans to animal modelsRF1AG071515 · NIA · JOHNS HOPKINS UNIVERSITY · PI LU, HANZHANG · 2021 to 2021
$2.4M
Huntington's Disease biomarkers and therapeuticsR01NS082338 · NINDS · JOHNS HOPKINS UNIVERSITY · PI DUAN, WENZHEN · 2013 to 2017
$2.0M
Brain oxygen consumption as an MRI biomarker of neurodegeneration in a model of Alzheimer?s diseaseR21AG058413 · NIA · JOHNS HOPKINS UNIVERSITY · PI LU, HANZHANG · 2018 to 2019
$465k
Characterization and validation of cerebrovascular reactivity (CVR) as a biomarker of vascular dementia in mouse modelsR21NS119960 · NINDS · JOHNS HOPKINS UNIVERSITY · PI WEI, ZHILIANG · 2021 to 2021
$465k
Developing HTS assays for identifying NLK activators to target Huntington's diseaseR21NS135139 · NINDS · JOHNS HOPKINS UNIVERSITY · PI DUAN, WENZHEN · 2023 to 2023
$450k
NIA NIH HHS R01 AG064792NIA NIH HHS R21 AG058413NIA NIH HHS RF1 AG071515NIBIB NIH HHS P41 EB031771NINDS NIH HHS R01 NS082338NINDS NIH HHS R01 NS124084NINDS NIH HHS R21 NS119960NINDS NIH HHS R21 NS135139
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cerebral blood flow (CBF)doseheart rate (HR)isofluranemouseMRIphase contrast (PC)respiration rate (RR)

Identifiers

PMID37123257
PMCPMC10130671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.